Drug maker to ask Health Canada to authorize COVID-19 shot for kids as young as five next week.
Pfizer is seeking approval in both Canada and the U.S. to allow use of the vaccine in kids aged five to 11.
Several media outlets report the drugmaker filed a formal request to the U.S. Food and Drug Administration today, and plans to submit a request to Health Canada in mid-October.
The FDA will meet on October 26th to discuss the issue.
Last week, Pfizer submitted data to both agencies to form a clinical trial on children in that age bracket.
The dose for younger children in the trial is about one-third the size of an adult shot.
NRP Want Help After Horses Hurt
Niagara Families Connected to Doctor
Teenager Hurt in St. Catharines Stabbing
One Driver Arrested of Two Hit and Runs
Unifor and GM reach tentative contract agreement
Marineland ships another three belugas to San Diego
PM Carney says Canada will Meet U.S tariffs “Dollar for Dollar”
Province Investing in Niagara Businesses